Testing effectiveness (Phase 2)UnknownNCT00007839What this trial is testingBeta Alethine in Treating Patients With Low-Grade LymphomaWho this might be right forLymphoma LifeTime Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00553501What this trial is testingEpratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 60
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00317785What this trial is testingTotal-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03198026What this trial is testingObinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's LymphomasWho this might be right forNon-Hodgkin's LymphomaAnn Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueAnn Arbor Stage II Follicular Lymphoma+16 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Testing effectiveness (Phase 2)Study completedNCT00071955What this trial is testingVaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's LymphomaWho this might be right forLymphoma Genitope Corporation
Testing effectiveness (Phase 2)Ended earlyNCT00691652What this trial is testingClofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaWho this might be right forLymphoma OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)UnknownNCT00014664What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma PDL BioPharma, Inc.
Large-scale testing (Phase 3)WithdrawnNCT00551239What this trial is testingFludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWho this might be right forLeukemiaLymphoma CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00003572What this trial is testingTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT00053157What this trial is testingSargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more Roswell Park Cancer Institute 10
Large-scale testing (Phase 3)Study completedNCT00003938What this trial is testingLiposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer PatientsWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)Ended earlyNCT00079443What this trial is testingFR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Small Lymphocytic Lymphoma National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00004260What this trial is testingInterleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Mayo Clinic
Early research (Phase 1)Study completedNCT00003962What this trial is testingInterleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00005579What this trial is testingDolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma University of Vermont
Testing effectiveness (Phase 2)Ended earlyNCT00281879What this trial is testingDonor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 200
Early research (Phase 1)Study completedNCT00047164What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 89
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30